The WACC of Calliditas Therapeutics AB (CALTX.ST) is 6.7%.
| Range | Selected | |
| Cost of equity | 4.80% - 6.20% | 5.50% |
| Tax rate | 0.50% - 0.70% | 0.60% |
| Cost of debt | 7.00% - 37.10% | 22.05% |
| WACC | 4.9% - 8.5% | 6.7% |
| Category | Low | High |
| Long-term bond rate | 2.5% | 3.0% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 0.34 | 0.36 |
| Additional risk adjustments | 0.5% | 1.0% |
| Cost of equity | 4.80% | 6.20% |
| Tax rate | 0.50% | 0.70% |
| Debt/Equity ratio | 0.08 | 0.08 |
| Cost of debt | 7.00% | 37.10% |
| After-tax WACC | 4.9% | 8.5% |
| Selected WACC | 6.7% | |